Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy

被引:12
|
作者
Sahin, Irfan [1 ]
Gungor, Baris [2 ]
Ozkaynak, Berk [3 ]
Uzun, Fatih [4 ]
Kucuk, Suat Hayri [5 ]
Avci, Ilhan Iker [2 ]
Ozal, Ender [1 ]
Ayca, Burak [1 ]
Cetin, Sukru [1 ]
Okuyan, Ertugrul [1 ]
Dinckal, Mustafa Hakan [1 ]
机构
[1] Bagcilar Res & Educ Hosp, Dept Cardiol, Merkez Mahallesi Mimar Sinan Caddesi 6, TR-34200 Istanbul, Turkey
[2] Siyami Ersek Thorac & Cardiovasc Surg Ctr, Dept Cardiol, Istanbul, Turkey
[3] Bagcilar Res & Educ Hosp, Dept Cardiovasc Surg, Istanbul, Turkey
[4] Istanbul Mehmet Akif Ersoy Thorac & Cardiovasc Su, Dept Cardiol, Istanbul, Turkey
[5] Bagcilar Res & Educ Hosp, Dept Biochem, Istanbul, Turkey
关键词
Heart failure; cardiac transplantation; cardiomyopathy; myocarditis; Imaging; echocardiography; Cardiovascular; biochemistry; ACUTE MYOCARDIAL-INFARCTION; BRAIN NATRIURETIC PEPTIDE; ARGININE-VASOPRESSIN; INCREMENTAL VALUE; RAPID RULE; PLASMA; EXPRESSION; PRECURSOR; FIBROSIS; DISEASE;
D O I
10.1002/clc.22602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundCorrelation of increased copeptin levels with various cardiovascular diseases has been described. The clinical use of copeptin levels in patients with hypertrophic cardiomyopathy (HCM) has not been investigated before. HypothesisIn this study, we aimed to investigate the prognostic value of copeptin levels in patients with hypertrophic cardiomyopathy (HCM). Methods HCM was defined as presence of left ventricular wall thickness 15 mm in a subject without any concomitant disease that may cause left ventricular hypertrophy. Levels of copeptin and plasma N-terminal probrain natriuretic peptide (NT-proBNP) were evaluated prospectively in 24 obstructive HCM patients, 36 nonobstructive HCM patients, and 36 age- and sex-matched control subjects. Blood samples were collected in the morning between 7 and 9 am after overnight fasting. Patients were followed for 24 months. Hospitalization with diagnosis of heart failure/arrhythmia, implantable cardioverter-defibrillator implantation, and cardiac mortality were accepted as adverse cardiac events. ResultsCopeptin and NT-proBNP levels were higher in the HCM group compared with controls (14.1 vs 8.4 pmol/L, P < 0.01; and 383 vs 44 pg/mL, P < 0.01, respectively). Copeptin and NT-proBNP levels were higher in the obstructive HCM subgroup compared with the nonobstructive HCM subgroup (18.3 vs 13.1 pmol/L, P < 0.01; and 717 vs 223 pg/mL, P < 0.01, respectively). In multivariable logistic regression analysis, copeptin and NT-proBNP levels remained as independent predictors of heart failure (P < 0.01 for both) and adverse cardiac events (P < 0.01 for both). ConclusionsCopeptin and NT-proBNP levels were significantly higher in patients with obstructive HCM, and higher levels were associated with worse outcome.
引用
收藏
页码:32 / 37
页数:6
相关论文
共 50 条
  • [31] Left Ventricular Mass and the Outcome of Patients With Hypertrophic Cardiomyopathy
    Song, Ze-Zhou
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (04) : 399 - 399
  • [32] Do female patients with hypertrophic cardiomyopathy have a worse prognosis than male patients?
    Bonaventura, J.
    Vejtasova, V.
    Polakova, E.
    Rihakova, B.
    Veselka, J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1708 - 1708
  • [33] Elevated plasma levels of miR-29a are associated with hemolysis in patients with hypertrophic cardiomyopathy
    Ntelios, Dimitrios
    Meditskou, Soultana
    Efthimiadis, Georgios
    Pitsis, Antonios
    Nikolakaki, Eleni
    Girtovitis, Fotios
    Parcharidou, Despoina
    Zegkos, Thomas
    Kouidou, Sofia
    Karvounis, Haralampos
    Tzimagiorgis, Georgios
    CLINICA CHIMICA ACTA, 2017, 471 : 321 - 326
  • [34] Higher Plasma Fibrinogen Levels are Associated with Malignant Phenotype and Worse Survival in Patients with Glioblastomas
    Wang, Peng-Fei
    Meng, Zhe
    Song, Hong-Wang
    Yao, Kun
    Duan, Ze-Jun
    Li, Shou-Wei
    Yan, Chang-Xiang
    JOURNAL OF CANCER, 2018, 9 (11): : 2024 - 2029
  • [35] Atrial Cardiomyopathy Predicts Worse Outcome in Patients With Lung Cancer
    Ren, Mengdi
    Ma, Yuyan
    Wei, Meng
    Ning, Yuye
    Liu, Hui
    Shi, Xue
    Yao, Yu
    Guo, Fengwei
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [36] A Higher Neutrophil Count Before Thrombolysis Is Associated With Worse Outcome
    Maestrini, Ilaria
    Strbian, Daniel
    Gautier, Sophie
    Haapaniemi, Elena
    Moulin, Solene
    Sairanen, Tiina
    Dequatre-Ponchelle, Nelly
    Sibolt, Gerli
    Cordonnier, Charlotte
    Melkas, Susanna
    Leys, Didler
    Tatlisumak, Turgut
    Bordet, Regis
    STROKE, 2015, 46
  • [37] Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy
    Hamada, M
    Shigematsu, Y
    Minamino, N
    Kangawa, K
    Matsuo, H
    Hiwada, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 6276 - 6276
  • [38] Plasma osteopontin levels in patients with dilated and hypertrophic cardiomyopathy
    Podzimkova, J.
    Palecek, T.
    Kuchynka, P.
    Marek, J.
    Danek, B. A.
    Jachymova, M.
    Kalousova, M.
    Zima, T.
    Linhart, A.
    HERZ, 2019, 44 (04) : 347 - 353
  • [39] The energetic cost of contraction is higher in themyocardium of patients with hypertrophic cardiomyopathy
    Ingwall, Joanne S.
    CARDIOVASCULAR RESEARCH, 2014, 103 (02) : 192 - 193
  • [40] Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage
    Zweifel, Christian
    Katan, Mira
    Schuetz, Philipp
    Siegemund, Martin
    Morgenthaler, Nils G.
    Merlo, Adrian
    Mueller, Beat
    Christ-Crain, Mirjam
    BMC NEUROLOGY, 2010, 10